Italy Agency Cautious On Astrazeneca Jab For Over 55s


2021-01-30 19:28:38

Italy Agency Cautious On Astrazeneca Jab For Over 55s

AstraZeneca-Oxford University coronavirus vaccine is 3rd vaccine approved for use in the EU.

Rome, Italy:

Italy’s medicines agency on Saturday approved the AstraZeneca coronavirus vaccine for all adults but recommended alternatives be given to people aged over 55.

AIFA’s decision comes a day after the European Union gave the green light for the jab, but Germany’s vaccine commission recommended against using it on older people amid questions over its effectiveness that have been rejected by the company.

“AIFA authorises the AstraZeneca vaccine for the prevention of Covid-19 disease in individuals over the age of 18, as per European Medicines Agency guidance,” it said.

But it noted “a level of uncertainty” about claims of the jab’s effectiveness in people over the age of 55, because the age group was “poorly represented” in trials.

To help with the best use of the vaccine, it recommended “preferential use of the AstraZeneca vaccine, pending further data, in subjects between 18 and 55 years old, for whom more solid evidence is available”.

It urged the “preferential use of messenger RNA vaccines in older and/or more frail subjects”.

So-called mRNA vaccines include Pfizer/BioNTech and Moderna jabs, and are based on a new technology previously untested in a real-world situation.

Newsbeep

They use an inert snippet of genetic code from the coronavirus to trigger an immune response in the body that can repel the active virus.

Many of the other vaccines — including Oxford/AstraZeneca — are variants of the method used for flu jabs, based on a virus that has been killed and rendered harmless.

AstraZeneca earlier rejected German media questioning the vaccine’s effectiveness in over 65s.

“Reports that the AstraZeneca/Oxford vaccine efficacy is as low as eight percent in adults over 65 years are completely incorrect,” the firm said in a statement last Monday.

“In November, we published data in The Lancet demonstrating that older adults showed strong immune responses to the vaccine, with 100 percent of older adults generating spike-specific antibodies after the second dose,” it added.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)



Source link

49 Comments

  1. webpage January 30, 2021
  2. หวยงวดนี้ January 30, 2021
  3. Fvfcsnopy February 5, 2021
  4. FqhhGroom February 5, 2021
  5. LbsxGroom February 5, 2021
  6. Jbnbsting February 6, 2021
  7. AhkdGroom February 6, 2021
  8. KuikEvows February 7, 2021
  9. KbcxZece February 8, 2021
  10. Aqcfcupecteds February 10, 2021
  11. Nncssnopy February 10, 2021
  12. FqbbGroom February 12, 2021
  13. LabxGroom February 12, 2021
  14. Jbnvsting February 13, 2021
  15. AhbzGroom February 13, 2021
  16. JbbnGroom February 14, 2021
  17. KvaxZece February 15, 2021
  18. Donaldorimb February 17, 2021
  19. Nbnhsnopy February 18, 2021
  20. Fjjusnopy February 28, 2021
  21. KndnZece March 1, 2021
  22. MarcosEtess March 5, 2021
  23. Michaelhom March 8, 2021
  24. Michaelhom March 9, 2021
  25. Michaelhom March 10, 2021
  26. JeffreyGog March 11, 2021
  27. JeffreyGog March 12, 2021
  28. JeffreyGog March 13, 2021
  29. JeffreyGog March 14, 2021
  30. JeffreyGog March 15, 2021
  31. Stanleycak March 16, 2021
  32. Stanleycak March 17, 2021
  33. ThomasHaf March 18, 2021
  34. ThomasHaf March 19, 2021
  35. ThomasHaf March 20, 2021
  36. ElmerJearo March 22, 2021
  37. ElmerJearo March 23, 2021
  38. Jasoncok March 25, 2021
  39. Jasoncok March 27, 2021
  40. Jasoncok March 29, 2021
  41. Scottrhync March 30, 2021
  42. Scottrhync March 31, 2021
  43. Scottrhync April 2, 2021
  44. Scottrhync April 3, 2021
  45. Stevenstazy April 5, 2021
  46. Stevenstazy April 6, 2021
  47. BillyViz April 7, 2021
  48. BillyViz April 8, 2021
  49. JamesBrivy April 10, 2021

Leave a Reply